BioScience Health Innovations (BHIC) Invested Capital (2019 - 2025)
Historic Invested Capital for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $1.7 million.
- BioScience Health Innovations' Invested Capital rose 36206.82% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 36206.82%. This contributed to the annual value of $835240.0 for FY2024, which is 1245562.13% up from last year.
- As of Q3 2025, BioScience Health Innovations' Invested Capital stood at $1.7 million, which was up 36206.82% from $1.7 million recorded in Q2 2025.
- Over the past 5 years, BioScience Health Innovations' Invested Capital peaked at $1.7 million during Q2 2025, and registered a low of -$88990.0 during Q1 2023.
- Its 5-year average for Invested Capital is $328881.5, with a median of $25476.0 in 2022.
- As far as peak fluctuations go, BioScience Health Innovations' Invested Capital crashed by 12052.95% in 2021, and later surged by 1245562.13% in 2024.
- Quarter analysis of 5 years shows BioScience Health Innovations' Invested Capital stood at $81832.0 in 2021, then tumbled by 68.87% to $25476.0 in 2022, then crashed by 126.53% to -$6760.0 in 2023, then soared by 12455.62% to $835240.0 in 2024, then soared by 104.85% to $1.7 million in 2025.
- Its Invested Capital stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.3 million for Q1 2025.